Thalidomide in the treatment of leprosy
- PMID: 12361920
- DOI: 10.1016/s1286-4579(02)01645-3
Thalidomide in the treatment of leprosy
Abstract
Leprosy is a chronic infection of the skin and nerves caused by Mycobacterium leprae. Erythema nodosum leprosum (ENL) is a reactive state in lepromatous leprosy. Thalidomide has been used to treat ENL since the 1960s. One of its mechanisms of action is anti-inflammatory through selective inhibition of the pro-inflammatory cytokine TNF-alpha produced by monocytes.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
